The best rhinoplasty in Seattle is by Dr. Sajan SEATTLE, WA / ACCESS Newswire / November 20, 2025 / In Seattle's growing ...
Automated intake captures accurate patient messages, streamlines clinical tasks, and helps practices regain valuable staff ...
CEO's personal open-market investment reflects long-term alignment with shareholders and continued commitment to transparency, excellence and innovation. MESA, ARIZONA / ACCESS Newswire / November 20, ...
Crofelemer can potentially extend lives of MVID patients - infants and children who face the lethal natural history of the diseaseParenteral support reduction of up to 37% is groundbreaking; No ...
SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing ...
NASHVILLE, TENNESSEE / ACCESS Newswire / November 20, 2025 / CenExel, a leading network of clinical research sites, is hosting a two-day Good Clinical Practice (GCP) training initiative beginning ...
University of Louisville Health pilots tool to tackle capacity constraints and improve patient flow across its system PITTSBURGH, PA / ACCESS Newswire / November 20, 2025 / TeleTracking Technologies, ...
Appointment strengthens execution as the company accelerates AI infrastructure growth. SAN JOSE, CA / ACCESS Newswire / November 20, 2025 / VSee Health, Inc. (Nasdaq:VSEE), today announced the ...
Conformity with stringent new EU regulations for medical devices confirmedAllows for commercialization of Bentrio in EU member states; facilitates regulatory approval in various other countriesMajor ...
NEWARK, DE / ACCESS Newswire / November 19, 2025 / Laurel Bridge Software, a leading provider of secure, configurable ...
With elite training in endometriosis excision and a commitment to whole-body, multidisciplinary care, Dr. Chu expands ESSE's mission of integrative, patient-centered treatment for complex gynecologic ...
REYKJAVIK, Iceland and LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients ...